dan 2163 has been researched along with Recrudescence in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Relapse was determined by assessing changes in Positive and Negative Syndrome Scale (PANSS) total scores from baseline to 6 months (increased over 20% or 10% reaching 70)." | 5.91 | Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics. ( Cai, J; Gao, M; Huang, J; Huang, Y; Kang, D; Li, L; Liu, F; Long, Y; Ou, J; Peng, X; Shao, P; Shao, T; Shen, Y; Song, C; Su, Y; Sun, M; Wang, W; Wang, X; Wu, Q; Wu, R; Xiao, J; Xie, P; Yang, Y, 2023) |
| "Relapse was determined by assessing changes in Positive and Negative Syndrome Scale (PANSS) total scores from baseline to 6 months (increased over 20% or 10% reaching 70)." | 1.91 | Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics. ( Cai, J; Gao, M; Huang, J; Huang, Y; Kang, D; Li, L; Liu, F; Long, Y; Ou, J; Peng, X; Shao, P; Shao, T; Shen, Y; Song, C; Su, Y; Sun, M; Wang, W; Wang, X; Wu, Q; Wu, R; Xiao, J; Xie, P; Yang, Y, 2023) |
| "Treatment with olanzapine was also associated with a higher frequency of remission compared with other antipsychotic agents." | 1.33 | Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study. ( Alonso, J; Haro, JM; Lépine, JP; Novick, D; Ratcliffe, M; Suarez, D, 2006) |
| "The acute phase of schizophrenia is characterized by the presence of positive, negative and affective symptoms." | 1.31 | Acute phase of schizophrenia: impact of atypical antipsychotics. ( Azorin, JM, 2000) |
| "Ten adolescent cases are presented with regard to the efficacy, side effects and dosage of amisulpride." | 1.31 | [Initial experiences with amisulpride, an in Germany novel, atypical neuroleptic drug in treatment of adolescents with psychiatric disorders]. ( Göpel, C; Marcus, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J | 1 |
| Li, L | 1 |
| Shao, T | 1 |
| Sun, M | 1 |
| Wang, W | 1 |
| Xie, P | 1 |
| Wang, X | 1 |
| Yang, Y | 1 |
| Long, Y | 1 |
| Kang, D | 1 |
| Xiao, J | 1 |
| Su, Y | 1 |
| Peng, X | 1 |
| Huang, Y | 1 |
| Gao, M | 1 |
| Wu, Q | 1 |
| Song, C | 1 |
| Liu, F | 1 |
| Shao, P | 1 |
| Ou, J | 1 |
| Shen, Y | 1 |
| Huang, J | 1 |
| Wu, R | 1 |
| Barrimi, M | 1 |
| El Ghazouani, F | 1 |
| Zaimi, O | 1 |
| Oneib, B | 1 |
| Chen, YY | 1 |
| Huang, MC | 1 |
| Wu, KC | 1 |
| Yasugi, S | 1 |
| Garg, V | 1 |
| Been, G | 1 |
| Magoulas, P | 1 |
| Levine, SZ | 1 |
| Leucht, S | 1 |
| D'iakonov, AL | 1 |
| Lobanova, IV | 1 |
| Hermann, D | 1 |
| Heinz, A | 1 |
| Croissant, B | 1 |
| Mann, K | 1 |
| Lecrubier, Y | 1 |
| Quintin, P | 1 |
| Bouhassira, M | 1 |
| Perrin, E | 1 |
| Lancrenon, S | 1 |
| Haro, JM | 1 |
| Novick, D | 1 |
| Suarez, D | 1 |
| Alonso, J | 1 |
| Lépine, JP | 1 |
| Ratcliffe, M | 1 |
| Azorin, JM | 1 |
| Göpel, C | 1 |
| Marcus, A | 1 |
1 trial available for dan 2163 and Recrudescence
| Article | Year |
|---|---|
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
Topics: Adult; Affect; Amisulpride; Antipsychotic Agents; Attention; Basal Ganglia Diseases; Benzodiazepines | 2006 |
10 other studies available for dan 2163 and Recrudescence
| Article | Year |
|---|---|
Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Humans; Hyperprol | 2023 |
[Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Neuroleptic Malignant Syndr | 2018 |
Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Appetite; Dibenzothiazepines; Dose-Response Relationship, | 2008 |
Neuroleptic malignant syndrome.
Topics: Adult; Amisulpride; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relation | 2010 |
Attaining and sustaining remission of predominant negative symptoms.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Double-Blin | 2013 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benz | 2012 |
Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.
Topics: Alcohol Withdrawal Delirium; Amisulpride; Antipsychotic Agents; Drug Therapy, Combination; Humans; M | 2004 |
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studie | 2006 |
Acute phase of schizophrenia: impact of atypical antipsychotics.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Haloperidol; Humans; Prognosis; Recurrence; Risper | 2000 |
[Initial experiences with amisulpride, an in Germany novel, atypical neuroleptic drug in treatment of adolescents with psychiatric disorders].
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Drug Adminis | 2001 |